Medexpress.pl > Drugs and medical technology (en)

Access to new therapies is a chance of a lifetime for breast cancer patients

Piotr Wójcik

Published May 3, 2023 10:00

Access to new therapies is a chance of a lifetime for breast cancer patients - Header image

Interview with Magdalena Cardinal, president of the OmeaLife Foundation

Breast cancer patients need new therapies that we know are already available worldwide.

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Download this article in .pdf format

Topics

OmeaLife / Magdalena Kardynał / rak piersi / onkologia

Inverted benefit pyramid a lifesaver for inefficient health care system Dec. 11, 2024

Dec. 11, 2024

NIO-PIB organizes training prior to KSO implementation Nov. 28, 2024

Nov. 28, 2024

Timetable for implementation of the National Cancer Strategy in the work list of the Council of Ministers Nov. 26, 2024

Nov. 26, 2024

New diagnostic tests may reduce chemotherapy use. There are results from the study Nov. 12, 2024

Nov. 12, 2024

Polish women are not taking advantage of mammograms. Will invitations that save lives return? Oct. 25, 2024

Oct. 25, 2024

Inverted benefit pyramid a lifesaver for inefficient health care system Dec. 11, 2024

Dec. 11, 2024

NIO-PIB organizes training prior to KSO implementation Nov. 28, 2024

Nov. 28, 2024

Timetable for implementation of the National Cancer Strategy in the work list of the Council of Ministers Nov. 26, 2024

Nov. 26, 2024

New diagnostic tests may reduce chemotherapy use. There are results from the study Nov. 12, 2024

Nov. 12, 2024

Polish women are not taking advantage of mammograms. Will invitations that save lives return? Oct. 25, 2024

Oct. 25, 2024

Szukaj nowych pracowników

Dodaj ogłoszenie o pracę za darmo

Dodaj w 2 minuty

Regulamin

Lub znajdź wyjątkowe miejsce pracy!

Najciekawsze oferty pracy (przewiń)

Technik Farmaceutyczny - Gdynia Ul. Chwaszczyńska

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Technik Farmaceutyczny - Gdańsk Ul. Jana Pawła II

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Technik Farmaceutyczny - Gdańsk Ul. Kołobrzeska

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Technik Farmaceutyczny - Ełk

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Technik Farmaceutyczny - Kraków (pół etatu)

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Strzelno - ul. Raj

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Grodków Ul. Reymonta

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Łódź Ul. Ujście

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Lębork

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Łomża

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Wrocław Ul. Powstańców Śląskich

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Kierownik Apteki - Warszawa (Bemowo)

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Kierownik Apteki - Goleniów Ul. Dworcowa

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Kierownik Apteki - Kościan Ul. Szczepanowskiego

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Brzeziny

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Zobacz więcej ogłoszeń

Read also

Monosnap iTV Sejm - transmisje - Sejm Rzeczypospol (18)

Parliamentary Health Committee - opioid sales - live June 27, 2024

June 27, 2024

July reimbursement list: Changes you need to know about July 9, 2024

July 9, 2024

AOTMiT: The Transparency Council will evaluate drugs for UC, SMA and phenylketonuria, among others. July 31, 2024

July 31, 2024

Stop Friedreich's Ataxia Aug. 5, 2024

Aug. 5, 2024

Depressive episodes in bipolar disorder. Pediatric population needs reimbursement Sept. 26, 2024

Sept. 26, 2024

AOTMiT: Transparency Council on diabetes, infertility and meningococcal vaccination, among others Oct. 4, 2024

Oct. 4, 2024

KPL: Drug production must be exempt from power constraints Nov. 22, 2024

Nov. 22, 2024

AOTMiT: The Transparency Council will evaluate drugs, health programs and benefits Dec. 6, 2024

Dec. 6, 2024

Parliamentary Health Committee - opioid sales - live June 27, 2024

June 27, 2024

July reimbursement list: Changes you need to know about July 9, 2024

July 9, 2024

AOTMiT: The Transparency Council will evaluate drugs for UC, SMA and phenylketonuria, among others. July 31, 2024

July 31, 2024

Stop Friedreich's Ataxia Aug. 5, 2024

Aug. 5, 2024

Depressive episodes in bipolar disorder. Pediatric population needs reimbursement Sept. 26, 2024

Sept. 26, 2024

AOTMiT: Transparency Council on diabetes, infertility and meningococcal vaccination, among others Oct. 4, 2024

Oct. 4, 2024

KPL: Drug production must be exempt from power constraints Nov. 22, 2024

Nov. 22, 2024

AOTMiT: The Transparency Council will evaluate drugs, health programs and benefits Dec. 6, 2024

Dec. 6, 2024

Access to new therapies is a chance of a lifetime for breast cancer patients

Content locked

Similar articles

Inverted benefit pyramid a lifesaver for inefficient health care system Dec. 11, 2024

NIO-PIB organizes training prior to KSO implementation Nov. 28, 2024

Timetable for implementation of the National Cancer Strategy in the work list of the Council of Ministers Nov. 26, 2024

New diagnostic tests may reduce chemotherapy use. There are results from the study Nov. 12, 2024

Polish women are not taking advantage of mammograms. Will invitations that save lives return? Oct. 25, 2024

Inverted benefit pyramid a lifesaver for inefficient health care system Dec. 11, 2024

NIO-PIB organizes training prior to KSO implementation Nov. 28, 2024

Timetable for implementation of the National Cancer Strategy in the work list of the Council of Ministers Nov. 26, 2024

New diagnostic tests may reduce chemotherapy use. There are results from the study Nov. 12, 2024

Polish women are not taking advantage of mammograms. Will invitations that save lives return? Oct. 25, 2024

Szukaj nowych pracowników

Dodaj ogłoszenie o pracę za darmo

Najciekawsze oferty pracy (przewiń)

Technik Farmaceutyczny - Gdynia Ul. Chwaszczyńska

Technik Farmaceutyczny - Gdańsk Ul. Jana Pawła II

Technik Farmaceutyczny - Gdańsk Ul. Kołobrzeska

Technik Farmaceutyczny - Ełk

Technik Farmaceutyczny - Kraków (pół etatu)

Magister Farmacji - Strzelno - ul. Raj

Magister Farmacji - Grodków Ul. Reymonta

Magister Farmacji - Łódź Ul. Ujście

Magister Farmacji - Lębork

Magister Farmacji - Łomża

Magister Farmacji - Wrocław Ul. Powstańców Śląskich

Kierownik Apteki - Warszawa (Bemowo)

Kierownik Apteki - Goleniów Ul. Dworcowa

Kierownik Apteki - Kościan Ul. Szczepanowskiego

Magister Farmacji - Brzeziny

Read also

Parliamentary Health Committee - opioid sales - live June 27, 2024

July reimbursement list: Changes you need to know about July 9, 2024

AOTMiT: The Transparency Council will evaluate drugs for UC, SMA and phenylketonuria, among others. July 31, 2024

Stop Friedreich's Ataxia Aug. 5, 2024

Depressive episodes in bipolar disorder. Pediatric population needs reimbursement Sept. 26, 2024

AOTMiT: Transparency Council on diabetes, infertility and meningococcal vaccination, among others Oct. 4, 2024

KPL: Drug production must be exempt from power constraints Nov. 22, 2024

AOTMiT: The Transparency Council will evaluate drugs, health programs and benefits Dec. 6, 2024

Parliamentary Health Committee - opioid sales - live June 27, 2024

July reimbursement list: Changes you need to know about July 9, 2024

AOTMiT: The Transparency Council will evaluate drugs for UC, SMA and phenylketonuria, among others. July 31, 2024

Stop Friedreich's Ataxia Aug. 5, 2024

Depressive episodes in bipolar disorder. Pediatric population needs reimbursement Sept. 26, 2024

AOTMiT: Transparency Council on diabetes, infertility and meningococcal vaccination, among others Oct. 4, 2024

KPL: Drug production must be exempt from power constraints Nov. 22, 2024

AOTMiT: The Transparency Council will evaluate drugs, health programs and benefits Dec. 6, 2024

Medexpress

About us

Follow us

Zapisz się do newslettera